DUBLIN, Ohio, Jan. 8, 2020 — Cordis, a Cardinal Health company, has been awarded a group purchasing agreement for six product categories of endovascular products with Premier. Starting Feb. 1, 2020, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for endovascular products.
“We are excited to add our endovascular devices, diagnostic and interventional products to the overall product mix available to Premier members,” said Patrick Holt, president of Cordis. “These products bring great clinical value to patients and economic value to Premier’s members along with new pricing options.”
The full list of products includes:
- Diagnostic and Interventional Radiology (DIR) Catheters;
- DIR Guidewires;
- DIR Balloon Catheters;
- Carotid and Embolic Protection;
- Peripheral and Biliary Bare Metal Stents;
- Interventional Sheaths and Introducers
Premier is a leading healthcare improvement company, uniting an alliance of approximately 4,000 U.S. hospitals and 175,000 other providers to transform healthcare. With integrated data and analytics, collaboratives, supply chain solutions, and advisory and other services, Premier enables better care and outcomes at a lower cost.
About Cardinal Health
Cardinal Health, Inc. is a global, integrated healthcare services and products company, providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices worldwide. The company enhances supply chain efficiency for clinically proven medical products, pharmaceuticals and cost-effective solutions. To combat prescription drug misuse, the Cardinal Health Foundation and its education partners created Generation Rx, a national drug prevention education and awareness program. The Foundation actively supports an array of other solutions, including efforts to reduce opioid prescribing, promote drug take back and safe disposal and expand collaborative community work.